S Todo

Author PubWeight™ 628.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 FK 506 for liver, kidney, and pancreas transplantation. Lancet 1989 13.70
2 Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993 8.76
3 The many faces of multivisceral transplantation. Surg Gynecol Obstet 1991 6.89
4 Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery 1991 5.92
5 Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 1989 5.78
6 Refinements in the surgical technique of liver transplantation. Semin Liver Dis 1985 5.70
7 Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc 1990 4.90
8 A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet 1985 4.29
9 Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc 1987 4.21
10 Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet 1990 4.18
11 Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994 4.16
12 Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989 4.12
13 Baboon-to-human liver transplantation. Lancet 1993 4.01
14 Replacement of donor lymphoid tissue in small-bowel transplants. Lancet 1991 3.85
15 Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc 1987 3.73
16 Transplantation of multiple abdominal viscera. JAMA 1989 3.59
17 Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991 3.57
18 Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation 1986 3.54
19 IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun 1987 3.46
20 Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc 1991 3.40
21 Kidney transplantation under FK 506 immunosuppression. Transplant Proc 1991 3.31
22 Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery 1990 3.18
23 Liver transplantation before 1 year of age. J Pediatr 1987 3.15
24 In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc 1988 3.15
25 The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation 1991 3.14
26 Biliary tract complications in human orthotopic liver transplantation. Transplantation 1987 2.95
27 Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc 1988 2.87
28 The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation 1990 2.79
29 THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun 1987 2.75
30 Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet 1990 2.66
31 Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc 1990 2.60
32 Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation 1990 2.59
33 Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc 1991 2.59
34 A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc 1991 2.49
35 Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc 1990 2.48
36 Upper abdominal exenteration with liver replacement: a modification of the "cluster" procedure. Transplant Proc 1990 2.40
37 Hepatotrophic effects of FK506 in dogs. Transplantation 1991 2.39
38 Liver transplantation across ABO blood groups. Surgery 1986 2.39
39 Toxicology of FK-506 in the Lewis rat. Transplant Proc 1987 2.37
40 The antibody crossmatch in liver transplantation. Surgery 1986 2.33
41 The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994 2.32
42 Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998 2.31
43 The effects of FK 506 on renal function after liver transplantation. Transplant Proc 1990 2.31
44 Animal research in liver transplantation with special reference to the dog. Semin Liver Dis 1985 2.28
45 The hepatotropic influence of cyclosporine. Surgery 1990 2.27
46 Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc 1991 2.26
47 Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1995 2.25
48 Three years clinical experience with intestinal transplantation. J Am Coll Surg 1994 2.20
49 Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc 1990 2.15
50 Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation 1993 2.14
51 FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation 1990 2.13
52 Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg 1987 2.11
53 The side effects of FK 506 in humans. Transplant Proc 1990 2.08
54 Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 1997 2.05
55 Should the cement mantle around the femoral component be thick or thin? J Bone Joint Surg Br 2003 2.05
56 Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet 1995 2.04
57 Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet 1989 2.01
58 Low flow venovenous bypasses in small dogs and pediatric patients undergoing replacement of the liver. Surg Gynecol Obstet 1986 2.00
59 Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998 1.99
60 Pathology of human intestinal transplantation. Gastroenterology 1996 1.98
61 FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. Lancet 1990 1.94
62 Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 1987 1.90
63 Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988 1.89
64 Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc 1991 1.89
65 Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg 1992 1.85
66 The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992 1.83
67 Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet 1989 1.82
68 Corrective treatment and anatomic considerations for laparoscopic cholecystectomy injuries. J Am Coll Surg 1994 1.81
69 A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy. Am J Transplant 2009 1.81
70 Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc 1990 1.80
71 Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc 1993 1.78
72 Use of FK 506 in pediatric patients. Transplant Proc 1991 1.77
73 Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc 1991 1.75
74 Factors in the Development of Liver Transplantation. Transplant Proc 1985 1.74
75 Hepatic artery in liver transplantation. Transplant Proc 1987 1.73
76 Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998 1.72
77 The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg 1996 1.71
78 Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. Transplant Proc 1990 1.71
79 Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991 1.71
80 Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc 1991 1.69
81 Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? Transplantation 1989 1.67
82 Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J 2000 1.66
83 Liver transplantation: an unfinished product. Transplant Proc 1989 1.61
84 Liver transplantation for polycystic liver disease. Arch Surg 1990 1.61
85 The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc 1991 1.60
86 Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997 1.59
87 Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995 1.59
88 The spectrum of portal vein thrombosis in liver transplantation. Ann Surg 1991 1.58
89 Irreducible indirect inguinal hernia containing uterus, ovaries, and Fallopian tubes. Hernia 2011 1.57
90 Oral glucose tolerance test in liver recipients treated with FK 506. Transplant Proc 1990 1.56
91 The biological basis of and strategies for clinical xenotransplantation. Immunol Rev 1994 1.56
92 Piggyback orthotopic intestinal transplantation. Surg Gynecol Obstet 1993 1.55
93 Mucosal damage and recovery of the intestine after prolonged preservation and transplantation in dogs. Transplantation 2001 1.55
94 Morphological monitoring of human small bowel allografts. Transplant Proc 1993 1.52
95 The effect of FK-506 on hyperacute rejection in presensitized rats. Transplant Proc 1987 1.49
96 Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40. J Am Coll Surg 1997 1.47
97 Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol 1989 1.45
98 Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation 1992 1.45
99 Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. Transplantation 1995 1.45
100 Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988 1.45
101 Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 1988 1.45
102 Adverse effects associated with the use of FK 506. Transplant Proc 1991 1.41
103 Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med 1998 1.41
104 A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation. Transplant Proc 1991 1.40
105 Venous-right atrial bypass for superior vena cava thrombosis during orthotopic liver transplantation. Transplantation 1997 1.39
106 Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc 1988 1.38
107 Rapid Flush Technique for Donor Hepatectomy: Safety and Efficacy of an Improved Method of Liver Recovery for Transplantation. Transplant Proc 1988 1.37
108 Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997 1.36
109 FK 506 as a growth control factor. Transplant Proc 1990 1.36
110 Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997 1.36
111 OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc 1987 1.35
112 Biopharmaceutical aspects of FK-506. Transplant Proc 1987 1.34
113 Assay of FK 506 in plasma. Transplant Proc 1990 1.32
114 Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol 1992 1.32
115 Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature. Oncogene 2007 1.31
116 Tibiofemoral movement 3: full flexion in the living knee studied by MRI. J Bone Joint Surg Br 2000 1.31
117 Excisional therapy for benign hepatic lesions. Surg Gynecol Obstet 1990 1.31
118 Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology 1987 1.30
119 Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc 1990 1.30
120 Small bowel and liver/small bowel transplantation in children. Semin Pediatr Surg 1993 1.30
121 Canine total orthotopic small bowel transplantation under FK 506. Transplant Proc 1991 1.29
122 An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 2000 1.29
123 Endotoxemia and human liver transplantation. Transplant Proc 1989 1.28
124 Current status of intestinal transplantation in children. J Pediatr Surg 1998 1.28
125 The effect of FK 506 and CyA on the Lewis rat renal ischemia model. Transplant Proc 1990 1.28
126 Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. Transplant Proc 1992 1.26
127 Analysis of surgical complications after 397 hepatic transplantations. Surg Gynecol Obstet 1990 1.25
128 The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation. Transplantation 1991 1.24
129 Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 1990 1.24
130 Infectious complications after small bowel transplantation in adults. Transplant Proc 1994 1.24
131 Role of bile and bile salts on cyclosporine absorption in dogs. Transplant Proc 1987 1.24
132 Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion. J Clin Pharmacol 1993 1.23
133 Experience with primary liver transplantation across ABO blood groups. Transplant Proc 1987 1.23
134 Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer 1988 1.22
135 Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am J Pathol 1990 1.21
136 Liver transplantation in older patients. N Engl J Med 1987 1.20
137 Somatic mutations of the APC gene in primary breast cancers. Am J Pathol 2000 1.19
138 Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. Ann Surg 1987 1.19
139 Childbearing after liver transplantation. Transplantation 1990 1.19
140 Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts. Hepatology 1992 1.18
141 Hypercalcemia in children presenting with acute lymphoblastic leukemia. Int J Hematol 1997 1.18
142 Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans. Surg Gynecol Obstet 1993 1.18
143 Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer. Br J Cancer 2012 1.17
144 Studies of the hepatotrophic qualities of FK 506 and CyA. Transplant Proc 1990 1.14
145 Renal artery reconstruction for harvesting injuries in kidney transplantation with particular reference to the use of vascular allografts. Transpl Int 1988 1.14
146 Hepatic resection for cystic lesions of the liver. Ann Surg 1993 1.14
147 A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res 1996 1.13
148 Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology 1991 1.13
149 Indications for pediatric liver transplantation. J Pediatr 1987 1.12
150 Clinical intestinal transplantation: focus on complications. Transplant Proc 1992 1.11
151 Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988 1.11
152 Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide. Hepatology 1999 1.10
153 Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis 1992 1.09
154 Nutritional management of intestinal transplant recipients. Transplant Proc 1993 1.09
155 Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant 1997 1.09
156 Cancer arising in a choledochal cyst in a 12-year-old girl. J Pediatr Surg 1990 1.09
157 Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. Transplant Proc 1990 1.08
158 Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc 1993 1.08
159 Treatment of upper abdominal malignancies with organ cluster procedures. Clin Transplant 1990 1.07
160 Cytomegalovirus disease in intestinal transplantation. Transplant Proc 1995 1.07
161 Liver transplantation under cyclosporine: a decade of experience. Transplant Proc 1991 1.07
162 Adenoviral infections in pediatric liver transplant recipients. JAMA 1987 1.06
163 Endoscopy is essential for early detection of rejection in small bowel transplant recipients. Transplant Proc 1994 1.06
164 Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates. Am J Transplant 2012 1.06
165 Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Am J Pathol 1993 1.05
166 Current status of FK 506 in liver transplantation. Transplant Proc 1991 1.04
167 The UW solution for canine kidney preservation. Its specific effect on renal hemodynamics and microvasculature. Transplantation 1989 1.04
168 The influence of donor and recipient strains in isolated small bowel transplantation in rats. Transplant Proc 1994 1.04
169 Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 1992 1.04
170 Expressive dysphasia possibly related to FK506 in two liver transplant recipients. Transplantation 1990 1.04
171 Pediatric liver transplantation. Transplant Proc 1987 1.03
172 Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990 1.03
173 Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. Br J Haematol 1994 1.03
174 Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc 1994 1.03
175 Amelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs. Am J Surg 1995 1.03
176 Isolated relapse of acute lymphoblastic leukemia in the breast of a young female. Pediatr Hematol Oncol 2008 1.03
177 Internal hernia and volvulus of the small bowel following liver transplantation. Transpl Int 1997 1.02
178 Endoscopies in pediatric small intestinal transplant recipients: five years experience. Am J Gastroenterol 1998 1.02
179 Intestinal transplantation in children under FK 506 immunosuppression. J Pediatr Surg 1993 1.02
180 Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas. Cancer Res 1999 1.00
181 Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma. Br J Cancer 2008 1.00
182 Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. Transplant Proc 1995 1.00
183 Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc 1996 1.00
184 Upper-abdominal exenteration in transplantation for extensive malignancies of the upper abdomen--an update. Transplantation 1991 1.00
185 Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc 1996 0.99
186 Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review. Rev Infect Dis 1991 0.99
187 High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 1988 0.99
188 The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. Hepatology 1987 0.99
189 Early infectious complications of liver-intestinal transplantation in children: preliminary analysis. Transplant Proc 1994 0.99
190 Rejection of human intestinal allografts: alone or in combination with the liver. Transplant Proc 1994 0.99
191 Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. Blood 2000 0.99
192 Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 1989 0.99
193 FK 506 dosage in human organ transplantation. Transplant Proc 1990 0.99
194 Liver transplantation for fulminant hepatic failure. Transplant Proc 1989 0.98
195 Liver retransplantation in adults: overall results and determinant factors affecting the outcome. Transplant Proc 1991 0.98
196 Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique. J Pharm Pharmacol 1999 0.98
197 The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. Transplantation 1992 0.98
198 Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation. Transplantation 1994 0.98
199 Prospects of clinical xenotransplantation. Transplant Proc 1994 0.98
200 A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients. Br J Cancer 2004 0.97
201 Venous jump grafts for liver transplantation in patients with portal vein thrombosis. Transplantation 1989 0.97
202 Preliminary experience with FK506 in thoracic transplantation. Transplantation 1991 0.97
203 Indocyanine green elimination test in orthotopic liver recipients. Hepatology 1996 0.96
204 Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. Transplant Proc 1992 0.96
205 Can adenine nucleotides predict primary nonfunction of the human liver homograft? Transpl Int 1994 0.95
206 Alveolar soft part sarcoma with lung metastases. Response to interferon alpha-2a? Med Pediatr Oncol 2001 0.95
207 Late mortality and morbidity after liver transplantation. Transplant Proc 1987 0.95
208 Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer. Oncogene 1999 0.95
209 Is multiple organ failure a contraindication for liver transplantation in children? Transplant Proc 1987 0.95
210 Liver transplantation in black recipients: Pittsburgh. Transplant Proc 1989 0.95
211 Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation. Transplant Proc 1996 0.95
212 Endogenous endotoxemia during orthotopic liver transplantation in dogs. Transplant Proc 1989 0.94
213 ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates. Am J Transplant 2013 0.94
214 Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. Transplant Proc 1994 0.94
215 Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int J Oncol 1998 0.94
216 One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc 1995 0.94
217 Bleeding disorder as the first symptom of biliary atresia. Eur J Pediatr Surg 2005 0.94
218 Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. Transplant Proc 1991 0.94
219 Acute invasive sinusitis due to Trichoderma longibrachiatum in a liver and small bowel transplant recipient. Clin Infect Dis 1998 0.93
220 FK 506 versus cyclosporine in pediatric liver transplantation. Transplant Proc 1991 0.93
221 Right trisegmentectomy with a synthetic vena cava graft. Arch Surg 1988 0.93
222 Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. Transplant Proc 1990 0.93
223 Cytomegalovirus infection after intestinal transplantation in children. Clin Infect Dis 1997 0.93
224 Anatomic variability of rejection in intestinal allografts after pediatric intestinal transplantation. J Pediatr Gastroenterol Nutr 1998 0.92
225 Chimerism analysis on mononuclear cells in the CSF after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997 0.91
226 Liver transplantation for Alagille's syndrome. Arch Surg 1993 0.91
227 Cyclosporine G Analysis and Monitoring by High-Pressure Liquid Chromatography. Transplant Proc 1986 0.91
228 Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 2001 0.91
229 The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation 1992 0.91
230 Mass screening of neuroblastoma in infancy. Am J Dis Child 1982 0.91
231 Electron microscopic observations on the cholesterol distributed in the epithelial cells of the gallbladder. Histochemistry 1975 0.91
232 Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation. Transplant Proc 1990 0.91
233 Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. Transplant Proc 1996 0.91
234 Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers. Transplant Proc 1989 0.91
235 The effect of small bowel transplantation on the morphology and physiology of intestinal muscle: a comparison of autografts versus allografts in dogs. Transplantation 1997 0.90
236 Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc 1993 0.90
237 Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation. Transplant Proc 1994 0.90
238 Prevention of spontaneous diabetes in BB rats with FK 506. Lancet 1990 0.90
239 Donor selection and surgical technique for en bloc liver-small bowel graft procurement. Transplant Proc 1993 0.90
240 Intestinal transplantation and bacterial overgrowth in humans. Transplant Proc 1994 0.90
241 Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc 1996 0.90
242 FK506 and pregnancy in liver transplant patients. Transplantation 1993 0.90
243 Liver transplantation for type I and type IV glycogen storage disease. Eur J Pediatr 1993 0.89
244 Second cutaneous neoplasms after acute lymphoblastic leukemia in childhood. Int J Hematol 1993 0.89
245 Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993 0.89
246 FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 2000 0.89
247 Perforation of the piriform recessus by a swallowed glass splinter presenting as pneumomediastinum in a child. Pediatr Surg Int 2004 0.89
248 Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD). Bone Marrow Transplant 1997 0.89
249 Serum and urine beta-2-microglobulin in hemophagocytic syndrome. Cancer 1995 0.88
250 Quality of life after small intestinal transplantation and among home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1999 0.88
251 Delay of gastric emptying measured by 13C-acetate breath test in neurologically impaired children with gastroesophageal reflux. Eur J Pediatr Surg 2005 0.88
252 FK506: a novel immunosuppressive agent. Characteristics of binding and uptake by human lymphocytes. Transplantation 1988 0.88
253 Endorectal pull-through of transplanted colon as part of intestinal transplantation. Surgery 1995 0.88
254 Liver transplantation for arteriohepatic dysplasia (Alagille's syndrome). Transpl Int 1992 0.88
255 Graft-versus-host disease in fully allogeneic small bowel transplantation: incidence of the disease and strain combinations. Transplant Proc 1993 0.88
256 Changes in renal function after liver transplantation under FK 506. Transplant Proc 1991 0.88
257 Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome. Warts, hypogammaglobulinemia, infections, and myelokathexis. Ann Hematol 2002 0.87
258 Accidental transplantation of malignant tumor from a donor to multiple recipients. Transplantation 1987 0.87
259 NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway. Oncogene 2006 0.87
260 Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report. Transplant Proc 1991 0.87
261 Excessive portal venous inflow as a cause of allograft dysfunction in small-for-size living donor liver transplantation. Transplant Proc 2001 0.87
262 Small intestinal transplantation for irreversible intestinal failure in children. Dig Dis Sci 1997 0.87
263 Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc 1992 0.87
264 Liver transplantation without the use of blood products. Arch Surg 1994 0.87
265 Morphological and functional changes in the tight junctions of the bile canaliculi induced by bile duct ligation. Cell Tissue Res 1978 0.86
266 Liver transplantation in patients with previous portasystemic shunt. Am J Surg 1990 0.86
267 Simple method for the collection of pancreatic islets by the use of Ficoll-Conray gradient. Endocrinol Jpn 1979 0.86
268 The effect of FK 506 on canine pancreatic islet cell function in beagle dogs. Transplant Proc 1991 0.86
269 The anterior route for arterial graft conduits in liver transplantation. Transpl Int 1989 0.86
270 Sudden death of a 21-year-old female with Williams syndrome showing rare complications. Pediatr Int 2000 0.86
271 Liver transplantation in patients over sixty years of age. Transplantation 1991 0.86
272 Non-T-cell-depleted HLA haploidentical stem cell transplantation based on feto-maternal microchimerism in pediatric patients with advanced malignancies. Bone Marrow Transplant 2004 0.86
273 Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. Transplant Proc 1991 0.86
274 Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin. Transplant Proc 1991 0.86
275 Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo. Oncol Rep 2000 0.85
276 FK 506: a new therapeutic agent for severe recalcitrant psoriasis. Transplant Proc 1991 0.85
277 A femoral component with proximal HA coating. An analysis of survival and fixation at up to ten years. J Bone Joint Surg Br 2003 0.85
278 Species-specific cyclosporine metabolism. Transplant Proc 1988 0.85
279 Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2(+) cancer patients. Br J Cancer 2004 0.85
280 Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 1991 0.85
281 Distribution of FK 506 in plasma lipoproteins in transplant patients. Transplant Proc 1991 0.85
282 Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron 1987 0.85
283 Late complications with gallbladder conduit biliary reconstruction after liver transplantation. Transplantation 1989 0.84
284 Effect of ischemia on the canine large bowel: a comparison with the small intestine. J Surg Res 1996 0.84
285 Interaction between FK 506 and cyclosporine in dogs. Transplant Proc 1991 0.84
286 Protective role of nitric oxide in ischemia and reperfusion injury of the liver. J Am Coll Surg 1999 0.84
287 Multivisceral and intestinal transplantation. Transplant Proc 1992 0.84
288 Early tolerance in pediatric liver allograft recipients. J Pediatr Surg 1994 0.84
289 Progress in liver transplantation. Adv Surg 1988 0.83
290 Antitumor effect of gamma-linolenic acid on cultured human neuroblastoma cells. Prostaglandins Leukot Med 1986 0.83
291 Clinical and endoscopic features of rejection in small bowel transplant recipients. Transplant Proc 1994 0.83
292 Sequential observation of liver cell regeneration after massive hepatic necrosis in auxiliary partial orthotopic liver transplantation. Mod Pathol 2000 0.83
293 "Munchausen by proxy" syndrome in a small bowel transplant recipient. Transplant Proc 1996 0.83
294 Effect of high concentrations of bile acids on cultured hepatocytes. Artif Organs 1998 0.83
295 Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. Transplantation 1990 0.83
296 Liver transplantation for primary biliary cirrhosis. Semin Liver Dis 1989 0.83
297 Strategy of FK 506 therapy in liver transplant patients: effect of graft function. Transplant Proc 1991 0.83
298 Blocking the CD28-B7 T-cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model. Transplantation 2000 0.83
299 Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. Am J Hosp Pharm 1992 0.83
300 Quality of life after intestinal transplantation and on total parenteral nutrition. Transplant Proc 1998 0.82
301 Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation. Gastroenterology 1997 0.82
302 Serum cytokine levels after small bowel transplantation in pigs. Transplant Proc 1994 0.82
303 Induction of graft acceptance after dog kidney or liver transplantation. Transplant Proc 1990 0.82
304 Effect of FK506 on insulin secretion in normal dogs. Metabolism 1992 0.82
305 Tube choledochoureterostomy: a simple method for bile diversion. J Invest Surg 1990 0.82
306 The maltose absorption test does not predict allograft rejection of small bowel transplantation in FK 506 immunosuppressed pigs. Transplant Proc 1994 0.82
307 Induction of S 100 protein by 5-bromo-2'-deoxyuridine in human neuroblastoma cell lines. Cancer Res 1988 0.82
308 Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver. Transplantation 2001 0.82
309 The use of clonidine for the treatment of high intestinal output following small bowel transplantation. Transplant Proc 1997 0.82
310 Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs. Res Commun Chem Pathol Pharmacol 1989 0.82
311 Does the permanent portacaval shunt for a small-for-size graft in a living donor liver transplantation do more harm than good? Am J Transplant 2007 0.81
312 Contrast examination of the small bowel in patients with small-bowel transplants: findings in 16 patients. AJR Am J Roentgenol 1993 0.81
313 Human liver xenotransplantation. Xeno 1993 0.81
314 Different response to epidermal growth factor of hepatocytes in cultures isolated from male or female rat liver. Inhibitor effect of estrogen on binding and mitogenic effect of epidermal growth factor. Gastroenterology 1987 0.81
315 Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. Transplant Proc 1991 0.81
316 Effect of FK 506 on spontaneous diabetes in BB rats. Diabetes 1990 0.81
317 Hepatic artery pseudoaneurysm ligation after orthotopic liver transplantation--a report of 7 cases. Transplantation 1992 0.81
318 Immunohistochemical study of enteric nervous system after small bowel transplantation in humans. Dig Dis Sci 1994 0.81
319 Isolation and primary culture of adult human hepatocytes. Ultrastructural and functional studies. Cell Tissue Res 1981 0.81
320 Histologic monitoring of human small bowel allografts with clinical correlation. Transplant Proc 1992 0.81
321 [Neurofibroma-associated left peroneal nerve palsy in a patient with acute lymphoblastic leukemia]. Rinsho Ketsueki 1989 0.81
322 Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature. Bone Marrow Transplant 2006 0.81
323 Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant 1999 0.81
324 Néel temperature of quasi-low-dimensional Heisenberg antiferromagnets. Phys Rev Lett 2005 0.81
325 Modified simple cold storage of rat livers with UW solution. Transplantation 1994 0.81
326 Hyperferritinemia in malignant histiocytosis and virus-associated hemophagocytic syndrome. N Engl J Med 1987 0.81
327 Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. Transplant Proc 1993 0.81
328 Infectious complications after small bowel transplantation in adults: an update. Transplant Proc 1996 0.80
329 Hemophagocytosis by leukemic blasts in a case of acute megakaryoblastic leukemia with t(16;21)(p11;q22). Int J Hematol 1999 0.80
330 FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 1991 0.80
331 A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent. Transplant Proc 1990 0.80
332 Preservation of livers with UW or Euro-Collins' solution. Transplantation 1988 0.80
333 Disturbance of microcirculation associated with prolonged preservation of dog livers under University of Wisconsin solution. Transplant Proc 1993 0.80
334 Management and algorithm for focal nodular hyperplasia of the liver in children. Eur J Pediatr Surg 2006 0.80
335 Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients. Br J Cancer 2002 0.80
336 Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722. Transplantation 2001 0.80
337 Intestinal transplantation in children after primary liver transplantation. Transplant Proc 1998 0.80
338 Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers. Int J Cancer 2000 0.80
339 Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation. Am J Kidney Dis 1988 0.80
340 Hyper-interleukin (IL)-6-naemia in haemophagocytic lymphohistiocytosis. Br J Haematol 1996 0.80
341 Endotoxemia is associated with renal dysfunction in liver transplantation recipients during the first postoperative week. Hepatogastroenterology 1995 0.80
342 FK 506 prevents spontaneous diabetes in the BB rat. Transplant Proc 1991 0.80
343 Lipid peroxidation, brush border, and neutrophil enzyme activity after small bowel preservation: a comparison of preservation solutions. Transplant Proc 1992 0.80
344 Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc 1995 0.80
345 Ischemia and reperfusion injury of the human colon and ileum. Transplant Proc 1996 0.80
346 Comparison of University of Wisconsin, Euro-Collins, and lactated Ringer's solutions in rat small bowel preservation for orthotopic small bowel transplantation. Transplant Proc 1994 0.80
347 Beta-glucan reflects liver injury after preservation and transplantation in dogs. J Invest Surg 1999 0.80
348 Extrinsic intestinal reinnervation after canine small bowel autotransplantation. Surgery 1998 0.80
349 Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma. Clin Exp Allergy 2012 0.79
350 Hemophagocytic syndrome in five patients with Epstein-Barr virus negative B-cell lymphoma. Cancer 1999 0.79
351 Procoagulant activity of human neuroblastoma cell lines, in relation to cell growth, differentiation and cytogenetic abnormalities. Jpn J Cancer Res 1989 0.79
352 Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Leuk Lymphoma 2000 0.79
353 Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation. Transplant Proc 1990 0.79
354 Pediatric liver transplantation. History, recent innovations, and outlook for the future. Clin Pediatr (Phila) 1993 0.79
355 The effect of FK 506 on small intestine allotransplantation in the rat. Transplant Proc 1990 0.79
356 The Denver-Pittsburgh liver transplant series. Clin Transpl 1987 0.79
357 Effect of rejection on electrophysiologic function of canine intestinal grafts: correlation with histopathology and Na-K-ATPase activity. J Invest Surg 1996 0.79
358 Effects of polyunsaturated fatty acids on vincristine-resistance in human neuroblastoma cells. Anticancer Res 1991 0.79
359 A novel hydroxyl radical scavenger, nicaraven, protects the liver from warm ischemia and reperfusion injury. Surgery 2000 0.79
360 Influence of graft perfusion pressure on graft viability after small bowel preservation and transplantation. Transplant Proc 1996 0.79
361 Development of a yeast stop codon assay readily and generally applicable to human genes. Am J Pathol 2001 0.79
362 Secondary lymphoid malignancy in two children with neuroblastoma. Med Pediatr Oncol 1996 0.79
363 Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. Transplantation 2000 0.79
364 Prospective evaluation of endoscopy in acute cellular rejection and cytomegalovirus infection. Transplant Proc 1996 0.79
365 Increased levels of alpha V-associated integrins in association with growth inhibition of cultured tumor cells by bromodeoxyuridine. Anticancer Res 1997 0.79
366 Liver transplantation for alcoholic liver disease: a consideration of reasons for and against. Alcohol Clin Exp Res 1989 0.79
367 The significance of surface changes on retrieved femoral components after total knee replacement. J Bone Joint Surg Br 2005 0.79
368 Evaluation of solutions for canine small bowel preservation. Transplant Proc 1996 0.79
369 Mechanisms of hamster kidney graft rejection in the rat. Transplant Proc 1994 0.79
370 Effects of hepatic CYP3A4 activity on disposition of micafungin in liver transplant recipients with markedly small-for-size grafts. Transplant Proc 2006 0.79
371 Evolution of immunosuppression in liver transplantation: contribution of cyclosporine. Transplant Proc 2004 0.79
372 Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures. Transpl Immunol 1993 0.79
373 Successful 48-hour preservation of the canine liver by modified simple hypothermic storage with University of Wisconsin solution. Transplant Proc 1995 0.79
374 Two-year experience with FK 506 in pediatric patients. Transplant Proc 1993 0.78
375 Effects of FK 506, mycophenolic acid, and bredinin on OKT-3-, PMA-, and alloantigen-induced activation molecule expression on cultured CD4+ and CD8+ human lymphocytes. Transplant Proc 1991 0.78
376 Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis. Transplant Proc 1994 0.78
377 Intestinal transplantation in children: five-year experience. Transplant Proc 1996 0.78
378 Intestinal transplantation. Annu Rev Med 1994 0.78
379 Selective synthesis and retention of 66k protein in a human neuroblastoma cell line (NCG) treated with a cytotoxic dosage of delta 12-prostaglandin J2. Prostaglandins 1987 0.78
380 Retinoic acid-induced apoptosis of the CHP134 neuroblastoma cell line is associated with nuclear accumulation of p53 and is rescued by the GDNF/Ret signal. Med Pediatr Oncol 2001 0.78
381 Role of xanthine-oxidase system in mucosal injury after intestinal preservation and transplantation. Transplant Proc 1993 0.78
382 Infections in pediatric liver recipients treated for acute rejection. Transplant Proc 1989 0.78
383 Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. Transplantation 1996 0.78
384 Glucose metabolism during liver transplantation in dogs. Anesth Analg 1987 0.78
385 Influence of continuous venovenous haemodiafiltration on the pharmacokinetics of tacrolimus in liver transplant recipients with small-for-size grafts. Clin Transplant 2003 0.78
386 Comparison of various lazaroid compounds for protection against ischemic liver injury. Transplantation 1997 0.78
387 Renal transplantation in baboons under FK 506. Transplant Proc 1990 0.78
388 Detection of complications after liver transplantation by technetium-99m mebrofenin hepatobiliary scintigraphy. Ann Nucl Med 1991 0.78
389 Comparison of superoxide dismutase, allopurinol, coenzyme Q10, and glutathione for the prevention of warm ischemic injury. Transplantation 1990 0.78
390 Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. J Pediatr Surg 1995 0.78
391 Effect of intrasplenic transplantation of immortalized human hepatocytes in the treatment of acetaminophen-induced acute liver failure SCID mice. Transplant Proc 2008 0.78
392 Functional analysis of hamster kidney xenografts in the rat: possible functional incompatibility and adaptation of hamster kidney grafts in a xenogenic rat environment. Transplant Proc 1996 0.78
393 Gastrointestinal posttransplant lymphoproliferative disease in children after small intestinal transplantation. Transplant Proc 1996 0.78
394 Successful liver transplantation for isoniazid-induced hepatic failure--a case report. Transplantation 1994 0.78
395 Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. Transplant Proc 1993 0.78
396 Effective fluconazole therapy for liver transplant recipients during continuous hemodiafiltration. Ther Drug Monit 2001 0.78
397 Bone marrow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis. Bone Marrow Transplant 1997 0.78
398 Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis. A survey of pediatric cases. Acta Paediatr Scand 1989 0.78
399 Gastrointestinal motility in the immediate postoperative period after intestinal transplantation, with special reference to acute rejection. Transplant Proc 1994 0.78
400 Comparative pharmacokinetics of cyclosporine and NVa2-cyclosporine in dogs. Transplant Proc 1987 0.78
401 Cold preservation of the human colon and ileum with University of Wisconsin solution. Clin Transplant 1999 0.78
402 Analogs of cyclic nucleotides in rat liver preservation. Transplantation 1998 0.78
403 Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483. J Am Coll Surg 1998 0.78
404 What is the limit of graft size for successful living donor liver transplantation in adults? Transplant Proc 2001 0.78
405 Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc 1992 0.78
406 Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts. Transplant Proc 1996 0.78
407 Vascular versus luminal flushing for preservation of canine small bowel. Transplant Proc 1994 0.78
408 Intestinal neuromuscular function after preservation and transplantation. J Surg Res 1996 0.78
409 Thymic localization of gallium-67 in pediatric patients with lymphoid and nonlymphoid tumors. J Nucl Med 1987 0.77
410 Intestinal motility after small bowel transplantation. Transplant Proc 1998 0.77
411 The use of transesophageal ultrasonography for the diagnosis of inferior vena caval outflow obstruction during liver transplantation. Transplantation 1992 0.77
412 Indication and strategy for adult living related liver transplantation. Transplant Proc 1999 0.77
413 Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats. Transplant Proc 1999 0.77
414 Cycloheximide reduces PGD2 or delta 12-PGJ2 cytotoxicity on NCG cells. Prostaglandins 1986 0.77
415 Cold ischemia time vs outcome of human liver transplantation using UW solution. Transplant Proc 1991 0.77
416 Eating difficulties in the pediatric small bowel recipient: the role of the nutritional management team. Transplant Proc 1994 0.77
417 Biochemical evidence of mucosal damage of intestinal grafts during cold preservation in University of Wisconsin, Euro-Collins, and lactated Ringer's solutions. Transplant Proc 1994 0.77
418 DFF45/ICAD restores cisplatin-induced nuclear fragmentation but not DNA cleavage in DFF45-deficient neuroblastoma cells. Oncogene 2007 0.77
419 Liver transplantation at the University of Pittsburgh, 1984 to 1990. Clin Transpl 1991 0.77
420 Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis. Cancer 1990 0.77
421 Evolution of surgical techniques in clinical intestinal transplantation. Transplant Proc 1994 0.77
422 Multivisceral allotransplantation in pigs. Transplant Proc 1996 0.77
423 Comparison between prenatally diagnosed choledochal cyst and type-1 cystic biliary atresia by CD56-immunostaining using liver biopsy specimens. Eur J Pediatr Surg 2007 0.77
424 Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats. Transplant Proc 2001 0.77
425 Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation. Transplant Proc 2001 0.77
426 Candidates for intestinal transplantation and possible indicators of outcome. Transplant Proc 1994 0.77
427 Cell kinetic studies of PGD2 cytotoxicity on the in vitro growth of human neuroblastoma. Prostaglandins Leukot Med 1986 0.77
428 Hospitalization and readmission of intestinal transplantation recipients. Transplant Proc 1994 0.77
429 Severe exfoliative rejection after intestinal transplantation in children. Transplant Proc 1996 0.77
430 Biliary tract complications in orthotopic adult liver transplantation. Am J Surg 1989 0.77
431 Effects of 5-bromo-2'-deoxyuridine on arachidonic acid metabolism of neuroblastoma and leukemia cells in culture: a possible role of endogenous prostaglandins in tumor cell proliferation and differentiation. Prostaglandins Leukot Med 1987 0.77
432 Management of massive hemobilia with angiographic embolization. Jpn J Surg 1983 0.77
433 [Malignant lymphoma of the central nervous system in a boy with immotile cilia syndrome]. Rinsho Ketsueki 1989 0.77
434 Assessment of hepatic viability during cold ischemic preservation. Transpl Int 1995 0.77
435 Effect of anticomplement agent K-76 COOH in hamster-to-rat and guinea pig-to-rat xenotransplantation. Transplant Proc 1995 0.77
436 Clinical considerations in orthotopic liver transplantation. Radiol Clin North Am 1987 0.76
437 Overview of FK506 in transplantation. Clin Transpl 1990 0.76
438 Renal function after conversion from cyclosporine to FK 506 in liver transplant patients. Transplant Proc 1991 0.76
439 Improved survival with cytomegalovirus infection after intestinal transplantation in children. Transplant Proc 1996 0.76
440 Intra-aortic prostaglandin E1 infusion in maturation of neuroblastoma. Experientia 1982 0.76
441 Infectious complications of pediatric liver transplantation under FK 506. Transplant Proc 1991 0.76
442 Abnormal serum phenylalanine-tyrosine ratio and hyperferritinemia in malignant histiocytosis. Pediatr Hematol Oncol 1988 0.76
443 Effect of endogenous adenosine augmentation on ischemia and reperfusion injury to the liver. Transplant Proc 1997 0.76
444 Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration. Br J Haematol 1995 0.76
445 Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer. Oncogene 2001 0.76
446 Successful allogeneic bone marrow transplantation in a case with myelodysplastic syndrome which developed following Fanconi anemia. Bone Marrow Transplant 1995 0.76
447 Pancreatic hormones and amino acid levels following liver transplantation. Hepatology 1987 0.76
448 Hepatic artery reconstruction for hepatic artery thrombosis after orthotopic liver transplantation. Arch Surg 1990 0.76
449 Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. Clin Transpl 1994 0.76
450 Distinct mechanism of human neuroblastoma cell adhesion to fibronectin. Clin Exp Metastasis 1991 0.76
451 Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line. Cancer Res 1987 0.76
452 Histological differentiation between prenatally diagnosed choledochal cyst and type I cystic biliary atresia using liver biopsy specimens. Eur J Pediatr Surg 2006 0.76
453 An improved technique for isolated perfusion of rat livers and an evaluation of perfusates. J Surg Res 1992 0.76
454 The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl 1995 0.76
455 Comparison of warm and cold ischemia of the canine small intestine. Eur Surg Res 1995 0.76
456 Fatty acid modification of cultured neuroblastoma cells by gamma linolenic acid relevant to its antitumor effect. Prostaglandins Leukot Med 1987 0.76
457 Acute pancreatitis after liver transplantation: incidence and contributing factors. Transpl Int 1995 0.76
458 Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. Transplant Proc 1999 0.76
459 Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine. Transplant Proc 1993 0.76
460 Variability in the interpretations of endoscopic findings in patients with intestinal transplantation. Transplant Proc 1996 0.75
461 Extrinsic reinnervation of the intestine after small bowel autotransplantation in dogs. Transplant Proc 1994 0.75
462 Specific effect of University of Wisconsin solution on renal hemodynamics and microvasculature in canine kidney preservation. Transplant Proc 1990 0.75
463 Perioperative treatment with phosphatidic acid inhibitor (Lisofylline leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model. Transplant Proc 1996 0.75
464 Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. Transplant Proc 1992 0.75
465 Intestinal retransplantation. Transplant Proc 1996 0.75
466 Pediatric liver transplantation from neonatal donors. Transpl Int 1992 0.75
467 Notes on FK 506. Transplant Proc 1991 0.75
468 Increased cyclosporine uptake by cells pretreated with FK506 and evidence for binding of both drugs to a common intracellular protein. Transplant Proc 1989 0.75
469 The transplantation of gastrointestinal organs. Gastroenterology 1993 0.75
470 Effect of preoperative thoracic duct drainage on canine kidney transplantation. J Invest Surg 1997 0.75
471 Tacrolimus (FK 506)-dependent tolerance after liver and heart xenotransplantation: inhibition of humoral response and acceptance of donor organs. Transplant Proc 1996 0.75
472 Sodium lactobionate sucrose solution for canine liver and kidney preservation. Transplant Proc 1993 0.75
473 Intestinal neurons in acute and chronic rejection after small bowel transplantation in dogs. Transplant Proc 1996 0.75
474 Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. Transplant Proc 1997 0.75
475 Is rejection a diffuse or localized process in small-bowel transplantation? Surg Endosc 1994 0.75
476 Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents. Transplant Proc 1997 0.75
477 Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist. Transplant Proc 1997 0.75
478 Circulating ICAM-1, E-selectin, IL-2 receptor, and HLA class I in human small bowel, liver, and small bowel-plus-liver transplant recipients. Transplantation 1995 0.75
479 Severe rhabdomyolysis associated with tacrolimus. Lancet 1995 0.75
480 Intestinal transplantation in 31 adults. Transplant Proc 1996 0.75
481 Lazaroid U74006F for canine small bowel preservation. Transplant Proc 1996 0.75
482 In-vitro interaction of a novel immunosuppressant, FK 506, and antacids. J Pharm Pharmacol 1991 0.75
483 Water, sodium, potassium, and D-xylose absorption in canine small bowel transplantation. Transplant Proc 1994 0.75
484 WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operation. Hosp Rec Study 1988 0.75
485 Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. Am J Kidney Dis 1998 0.75
486 Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. Transplant Proc 1994 0.75
487 Prolonged small bowel graft survival using photochemotherapy and low-dose FK 506. Transplant Proc 1996 0.75
488 Characteristics of graft-versus-host disease after Lewis-to-brown-Norway rat small bowel transplantation. Transplant Proc 1994 0.75
489 Long-term effect of jejunoileal autotransplantation on motility and transit time in canine small bowel. Transplant Proc 1994 0.75
490 Nutritional management of intestinal allograft recipients. Transplant Proc 1998 0.75
491 Protective effect of TNF-alpha and IL-1 beta inhibitor FR167653 on ischemia-reperfusion injury in rat small intestinal transplantation. Transplant Proc 1998 0.75
492 Histopathologic changes of antibody-mediated small bowel graft rejection in blood-transfused recipients. Transplant Proc 1996 0.75
493 Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report. Transplant Proc 1996 0.75
494 Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. Transplant Proc 1991 0.75
495 Influence of donor-recipient strain combinations on immunologic responses after allogeneic rat small bowel transplantation. Transplant Proc 1994 0.75
496 An automated and portable low-flow pulsatile perfusion system for organ preservation. Transpl Int 1996 0.75
497 Preformed antibodies in sensitized recipients: effect of immunoglobulin titer, class, and specificity on liver and heart allografts. Transplant Proc 1993 0.75
498 Effect of Chronic Therapy on Absorption and Disposition of Cyclosporine. Transplant Proc 1988 0.75
499 Cytokine profile in graft-versus-host disease after small bowel transplantation. Transplant Proc 1996 0.75
500 Glutamine metabolism of intestine grafts: influence of mucosal injury by prolonged preservation and transplantation. Transplant Proc 1996 0.75
501 Comparison of various lazaroid compounds for protection against ischemic liver injury. Transplant Proc 1997 0.75
502 An Analysis of the Causes of Death After Pediatric Liver Transplantation. Transplant Proc 1988 0.75
503 Hepatolithiasis in East Asia: comparison between Japan and China. J Gastroenterol Hepatol 1991 0.75
504 Basic considerations for the procurement of intestinal grafts. Transplant Proc 1994 0.75
505 A modified technique of orthotopic transplant of the kidney in rabbits. J Invest Surg 1989 0.75
506 Abnormal gastric emptying after intestinal transplantation. Transplant Proc 1994 0.75
507 Effect of CMV serology on outcome after clinical intestinal transplantation. Transplant Proc 1996 0.75
508 Levels of purine nucleoside phosphorylase (PNP) as a viability marker of nonparenchymal cells in cold preserved livers. Transplant Proc 1991 0.75
509 CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. Transplant Proc 1991 0.75
510 Influence of donor criteria on early outcome after intestinal transplantation. Transplant Proc 1997 0.75
511 Fluorometric study of the viability of rat liver grafts after simple cold storage with UW solution versus Euro-Collins solution. Transplant Proc 1991 0.75
512 Functional analysis of graft lamina propria associated lymphocytes from a recipient of a human cadaveric small bowel allograft primarily immunosuppressed with FK 506. Transplant Proc 1991 0.75
513 Lazaroid U-74500A for warm ischemia and reperfusion injury of the canine small intestine. J Am Coll Surg 1997 0.75
514 Intestinal transplantation at the University of Pittsburgh: six-year experience. Transplant Proc 1997 0.75
515 Management of childhood and adolescent thyroid carcinoma: long-term follow-up and clinical characteristics. Eur J Pediatr Surg 2006 0.75
516 Early infections in kidney transplant recipients under FK 506. Transplant Proc 1991 0.75
517 Use of the D-xylose absorption test in monitoring intestinal allografts. Transplant Proc 1994 0.75
518 Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. Transplant Proc 1995 0.75
519 Liver transplantation for hereditary tyrosinemia in the presence of hepatocellular carcinoma. Transplant Proc 1989 0.75
520 [Clinical experience with FK 506]. Presse Med 1991 0.75
521 [Evaluation of paresthesia of the throat and upper esophagus--with reference to stiffness in the shoulder and neck]. Jibiinkoka 1967 0.75
522 [Improved results of treatment in 30 cases of acute nonlymphocytic leukemia in childhood]. Gan To Kagaku Ryoho 1986 0.75
523 Long-term acceptance of allografts by in vivo gene transfer of regulatable adenovirus vector containing CTLA4IgG and loxP. Hum Gene Ther 2001 0.75
524 [Successful treatment of ectopic insulinoma. Report of a case (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1979 0.75
525 Cyclic AMP in neuroblastoma, ganglioneuroma and sympathetic ganglia. Experientia 1977 0.75
526 Pneumatosis cystoides intestinalis with abdominal free air in a 2-year-old girl after allogeneic bone marrow transplantation. Pediatr Hematol Oncol 1998 0.75
527 The effect of preservation fluid on the blood flow of pediatric liver allografts. Transplantation 1989 0.75
528 Separation of prostaglandins and thromboxane by two-dimensional thin-layer chromatography. J Chromatogr 1987 0.75
529 First case of cadaveric liver transplantation in Japan. J Hepatobiliary Pancreat Surg 1999 0.75
530 [Thymidine phosphorylase as a prognostic factors of breast cancers]. Nihon Rinsho 2000 0.75
531 [Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis: survey of pediatric cases in Japan]. Rinsho Ketsueki 1988 0.75
532 [ACTH unresponsiveness, a case of 13 years old boy (author's transl)]. Horumon To Rinsho 1979 0.75
533 [Structural study of black pigment gallstones]. Nihon Shokakibyo Gakkai Zasshi 1977 0.75
534 Liver allograft pathology in liver/small bowel or multivisceral recipients. Transplant Proc 1996 0.75
535 Malignant histiocytosis in childhood: clinical, cytochemical, and immunohistochemical studies of seven cases. Hum Pathol 1988 0.75
536 [Observations on hearing loss in higher frequencies with chronic otitis media in excessively noisy environments]. Nihon Jibiinkoka Gakkai Kaiho 1968 0.75
537 [A case of inflammatory fibrosarcoma of the retroperitoneum]. Nihon Shokakibyo Gakkai Zasshi 2001 0.75
538 Effect of dipyridamole on ischemia and reperfusion injury of canine liver. Transplant Proc 2001 0.75
539 [Prognosis of acute lymphoblastic leukemia, developing isolated testicular involvement at late relapse]. Rinsho Ketsueki 1984 0.75
540 Biochemical monitors of rejection in canine small bowel transplantation. Transplant Proc 1994 0.75
541 Initial studies with FK506 in renal transplantation. Cleve Clin J Med 1991 0.75
542 Correlation between elevated intratumoral thymidine phosphorylase and prognosis of node-positive breast carcinoma undergoing adjuvant doxifluridine treatment. Int J Oncol 2000 0.75
543 Distinct isozyme patterns of cyclic nucleotide phosphodiesterase in human neuroblastoma and ganglioneuroma; a possible marker of differentiation of neural crest-derived tumors and Schwann cells. Jpn J Cancer Res 1986 0.75
544 [Juvenile chronic myelocytic leukemia associated with neurofibromatosis and 45, XO karyotype (author's transl)]. Rinsho Ketsueki 1979 0.75
545 Serial analysis of MLL-AF4 chimeric message through successful bone marrow transplantation in a patient with t(4;11)-positive infant-ALL. Am J Hematol 2000 0.75
546 [Recombinant human granulocyte-colony stimulating factor (rhG-CSF) treatment for spleen abscess and periostitis in a patient with chronic granulomatous disease]. Rinsho Ketsueki 1992 0.75
547 [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia]. Gan To Kagaku Ryoho 1986 0.75
548 Circulating adhesion molecules and other soluble markers of immune activation in human small bowel and small bowel plus liver transplantation. Transplant Proc 1994 0.75
549 [Various factors contributing to the development of liver transplantation]. Masui 1998 0.75
550 Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupression. Surg Technol Int 1996 0.75
551 Liver allograft pathology in liver/small bowel or multivisceral recipients. Mod Pathol 1996 0.75
552 [Ataxia telangiectasia and acute lymphocytic leukemia. A case report of long-term survival]. Rinsho Ketsueki 1982 0.75
553 [Therapeutic response of 47 children with acute leukemia; the significance of cytomorphology in determining prognosis (author's transl)]. Rinsho Ketsueki 1981 0.75
554 Effect of FK 506 in the prophylaxis of autoimmune glomerulonephritis in NZB/WF1 mice. Transplant Proc 1991 0.75
555 Rat liver lipids during ex vivo warm and cold ischemia and reperfusion. J Surg Res 1993 0.75
556 [Therapeutic results of acute leukemia with hyperleukocytosis in children--the effect of exchange transfusion for induction therapy]. Rinsho Ketsueki 1988 0.75
557 Inhibition of thromboxane A2 synthesis by OKY-046 attenuates ischemia and reperfusion injury of the liver. Transplant Proc 1999 0.75
558 Role of local renin-angiotensin system in warm ischemia and reperfusion injury of the liver. Transplant Proc 2001 0.75
559 [Chemotherapy for B lymphoid malignancy in childhood--results in BLK88 protocol]. Rinsho Ketsueki 1996 0.75
560 Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice. Clin Transplant 1995 0.75
561 Intestinal and multivisceral transplantation. Radiol Clin North Am 1995 0.75
562 Comparison of in vitro electrophysiological function with histology and mucosal Na-K-ATPase activity in canine small bowel transplantation. Transplant Proc 1994 0.75
563 Donor lymphocyte infusion at unstable mixed chimerism in an allogeneic BMT recipient for chronic granulomatous disease. Bone Marrow Transplant 1998 0.75
564 Splenectomy in haemophagocytic lymphohistiocytosis: report of histopathological changes with CD19+ B-cell depletion and therapeutic results. Br J Haematol 2000 0.75
565 Pancreatitis following allogeneic bone marrow transplantation in a patient with aplastic anemia. Bone Marrow Transplant 1996 0.75
566 Liver transplantation today. Postgrad Med 1987 0.75
567 Transluminal ligation of bleeding angiodysplasia of the small bowel without need for surgical resection. Dig Dis Sci 1993 0.75
568 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma. Pediatr Radiol 1987 0.75
569 Severe tissue damage occurs during cold preservation of liver grafts. Transplant Proc 1993 0.75
570 [Eelctron microscopic observation on the etiology of cholesterosis of the gallbladder]. Nihon Shokakibyo Gakkai Zasshi 1974 0.75
571 Susceptibility to ischemia: the large bowel versus the small bowel. Transplant Proc 1994 0.75
572 [Clinical significance of hyperferritinemia in malignant histiocytosis and virus-associated hemophagocytic syndrome]. Rinsho Ketsueki 1988 0.75
573 Living liver donation for adult living-related liver transplantation. Transplant Proc 2000 0.75
574 Hyperphenylalaninemia in malignant histiocytosis and virus-associated hemophagocytic syndrome. Acta Paediatr Scand 1988 0.75
575 [Urotoxicity of enocitabine (BH-AC) and aclarubicin (ACM) in pediatric patients with hematological malignancies]. Rinsho Ketsueki 1988 0.75
576 Treatment for stage III-IV neuroblastoma patients: initial response to chemotherapy evaluated by biochemical parameters. Acta Paediatr Scand 1991 0.75
577 [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma]. Gan To Kagaku Ryoho 1984 0.75
578 Psychiatric evaluations of small intestine transplantation patients. Gen Hosp Psychiatry 1996 0.75
579 Novel CD40-IgG adenovirus-mediated gene therapy as a potent immunosuppressive treatment for liver transplantation in rats. Transplant Proc 2001 0.75
580 [Successful treatment of infantile chronic autoimmune hemolytic anemia with high-dose intravenous gamma globulin]. Rinsho Ketsueki 1986 0.75
581 [Transient diabetes mellitus induced by L-asparaginase in a patient with acute myeloblastic leukemia (author's transl)]. Rinsho Ketsueki 1981 0.75
582 Clinical intestinal transplantation. Clin Nutr 1996 0.75
583 [Intra-aortic prostaglandin E1 infusion in the treatment of advanced neuroblastoma]. Gan To Kagaku Ryoho 1983 0.75
584 Can adenine nucleotides predict primary nonfunction of the human liver homograft? Transplant Proc 1993 0.75
585 [Characterization of cAMP-dependent protein kinases by photoaffinity labeling (author's transl)]. Horumon To Rinsho 1981 0.75
586 The latest advances in liver transplantation at the pittsburgh transplantation institute: evolution of FK506, liver-intestinal transplantation, clinical xenotransplantation, and the induction of graft acceptance. Surg Technol Int 1994 0.75
587 Effect of glucose introduction to the lumen during cold ischemia in rat small bowel. Transplant Proc 1996 0.75
588 [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy]. Gan To Kagaku Ryoho 1990 0.75
589 [A pediatric case with blastic transformation of chronic myelogenous leukemia of adult type (author's transl)]. Rinsho Ketsueki 1980 0.75
590 Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma. Prog Clin Biol Res 1985 0.75
591 Role of adenosine 3'5'-cyclic monophosphate in antineoplastic effect of prostaglandins (PGE1, PGE2, PGD2 and PGA1) on human neuroblastoma cells. Prostaglandins Leukot Essent Fatty Acids 1988 0.75
592 APRV in patients with atelectasis after liver transplantation. Anaesth Intensive Care 2014 0.75
593 [Clinical features and therapeutic results in 14 cases of malignant histiocytosis in childhood]. Gan To Kagaku Ryoho 1987 0.75
594 [Interstitial nephritis developed during maintenance chemotherapy in a child with acute lymphocytic leukemia]. Rinsho Ketsueki 1988 0.75
595 [Exchange transfusion and combination chemotherapy in the treatment of 4 cases of childhood malignant histiocytosis]. Rinsho Ketsueki 1987 0.75
596 [Late relapse of acute promyelocytic leukemia (FAB M3) in childhood--characteristic therapeutic results of M3 compared to other types of non-lymphocytic leukemia]. Rinsho Ketsueki 1988 0.75
597 Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model. Transplant Proc 1999 0.75
598 Venovenous bypass using inferior mesenteric vein for portal decompression during orthotopic hepatic transplantation. J Am Coll Surg 1995 0.75
599 [Liver transplantation from brain dead patients]. Nihon Naika Gakkai Zasshi 2001 0.75
600 Intestinal transplantation with or without other abdominal organs: nutritional and dietary management of 50 patients. Transplant Proc 1994 0.75
601 Early clinical and histologic viability of human liver-small intestinal allografts after implantation. Clin Transplant 1994 0.75
602 Histologic spectrum of acute cellular rejection in human intestinal allografts. Transplant Proc 1996 0.75
603 [Post-transplant EBV-associated lymphoproliferative disorders--report of two cases]. Rinsho Ketsueki 1998 0.75
604 Cystic thymoma in a child: a rare case and review of the literature. Pediatr Surg Int 2007 0.75
605 [Acute megakaryoblastic leukemia in early childhood; report of two cases]. Rinsho Ketsueki 1988 0.75
606 Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation. Bone Marrow Transplant 1996 0.75
607 [Therapeutic results in 22 cases of childhood non-Hodgkin's lymphoma treated by ACOP combination chemotherapy]. Gan To Kagaku Ryoho 1987 0.75
608 Liver transplantation for hepatitis B: what have we learned and what does the future hold? Liver Transpl Surg 1995 0.75
609 [An adolescent case of myelodysplastic syndrome following aplastic anemia]. Rinsho Ketsueki 1989 0.75
610 [Bowel perforation due to disseminated candidiasis at initial remission induction in an infant with acute myelomonocytic leukemia]. Rinsho Ketsueki 1988 0.75
611 Gamma linolenic acid alters the cytotoxic activity of anticancer drugs on cultured human neuroblastoma cells. Anticancer Res 1990 0.75
612 Attenuation of hepatic ischemia and reperfusion injury by serine protease inhibitor, FUT-175, in dogs. Transplant Proc 2001 0.75
613 Endoscopic features of acute cellular rejection. Transplant Proc 1996 0.75
614 Combined liver-islet allotransplantation in man under FK 506. Transplant Proc 1991 0.75
615 Inhibition of type II phospholipase A(2) by LY329722 attenuates ischemia and reperfusion injury of canine livers. Transplant Proc 2001 0.75
616 [Mediastinal mass, large hepatomegaly and del(11) (q21q24) chromosome abnormality in a patient with acute monocytic leukemia]. Rinsho Ketsueki 1988 0.75
617 Effect of a new immunosuppressive agent, KF20444, in rat cardiac transplantation. Transplant Proc 1999 0.75
618 Microbial flora alterations in jejunum and colon after chemical bowel preparation before Kasai hepatoportojejunostomy. Eur J Pediatr Surg 2007 0.75
619 Effective esophageal balloon dilation for esophageal stenosis in recessive dystrophic epidermolysis bullosa. Eur J Pediatr Surg 2006 0.75
620 Elevation of cyclic nucleotides attenuates ischemia and reperfusion injury of liver. Transplant Proc 2001 0.75
621 Etoposide and cytosine arabinoside combination chemotherapy for refractory acute lymphocytic leukemia in childhood. J Clin Oncol 1986 0.75
622 [Comparison of crossing-over between 30-minute drip infusion vs 30-second injection of granisetron for nausea and vomitting with cisplatin]. Gan To Kagaku Ryoho 1998 0.75
623 Morphology of acute rejection and observation of lymphoproliferative hyperplastic reaction in FK 506 treated pigs after small bowel transplantation. Transplant Proc 1994 0.75
624 Elevated immunoreactive trypsinogen levels in pediatric patients with short bowel syndrome. Transplant Proc 1998 0.75
625 A short-course therapy with FTY720 prolongs allograft survival after canine kidney transplantation. Transplant Proc 1999 0.75
626 [Echinococcosis]. Ryoikibetsu Shokogun Shirizu 1999 0.75
627 Amelioration of liver damage induced by ischemia and reperfusion with FR167653; a newly synthesized cytokine suppressive antiinflammatory drug. Transplant Proc 1998 0.75
628 Monitoring of intestinal myoelectrical activity after isolated small bowel transplantation in FK 506 immunosuppressed pigs. Transplant Proc 1994 0.75
629 Long-term nutritional monitoring after clinical intestinal transplantation. Transplant Proc 1998 0.75
630 Alterations in donor small bowel neuromuscular transmission with preservation time using University of Wisconsin solution. Transplant Proc 1994 0.75
631 Serum ferritin in stage IV neuroblastoma. Am J Pediatr Hematol Oncol 1988 0.75
632 Procoagulant activity and tumor necrosis factor in rat hepatic allograft rejection. Hepatology 1991 0.75
633 Nitric oxide enhancement attenuates ischemia and reperfusion injury of canine livers. Transplant Proc 1999 0.75
634 Analysis of spleen cells in malignant histiocytosis in infancy. Leuk Lymphoma 1990 0.75
635 [Therapeutic effect of adjuvant combination chemotherapy in the treatment of 8 cases of childhood soft-tissue sarcoma]. Gan To Kagaku Ryoho 1987 0.75
636 Hemodynamic changes during acute rejection of small bowel allografts. Transplant Proc 1994 0.75
637 [TNM classification--pediatric tumors]. Gan To Kagaku Ryoho 1998 0.75
638 Risk factors for cytomegalovirus retinitis following bone marrow transplantation from unrelated donors in patients with severe aplastic anemia or myelodysplasia. Int J Hematol 2001 0.75
639 [Prognosis and preoperative imaging of patients with small hepatocellular carcinoma]. Gan To Kagaku Ryoho 1997 0.75
640 [Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child]. Gan To Kagaku Ryoho 1993 0.75
641 OKT4 epitope deficiency in a patient with acute myeloblastic leukemia. Am J Pediatr Hematol Oncol 1987 0.75
642 [Indication and system of living-related and cadaver liver transplantation in Japan]. Hokkaido Igaku Zasshi 2000 0.75
643 [Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy]. Gan To Kagaku Ryoho 1987 0.75
644 Human leukemia cells and mature lymphocytes induce platelet aggregation after removal of cell surface sialic acid. Nihon Ketsueki Gakkai Zasshi 1989 0.75